Targeted peptides challenge the collagen supplement market
655. The Collagen Lie: Why Your $30 Scoop Isn't Working (And the 3 Peptides That Actually Do
The episode argues that collagen’s usefulness may depend less on broad marketing claims than on peptide design, dosage, consistency, and the body tissue being targeted.
- 1Collagen type counts and source may matter less than whether peptides deliver targeted cellular signals.
- 2Aging, thyroid hormones, estrogen, and menopause can shape collagen production and maintenance.
- 3Different bioactive peptides are discussed for skin, cartilage, joints, and connective-tissue support.
Don't miss
Hornaman distinguishes three targeted peptide applications, showing why a collagen product’s intended tissue may matter more than its marketing claims.
The brief
Amie Hornaman opens by challenging a familiar supplement assumption: more collagen types or a more appealing source do not automatically make a product better.
The central argument is that optimized, bioactive peptides may matter more because they can support targeted cellular signaling rather than simply increase a collagen count.
The discussion connects collagen production and maintenance with aging, thyroid hormones, estrogen, and menopause, placing supplements within a broader hormonal context.
Hornaman highlights distinct peptide applications, including Fortigel for cartilage and joint support, Verisol for skin-related uses, and Tendo Forte for connective tissue.
The episode closes around practical variables that marketing often obscures: appropriate dosage, consistent use, and resistance training alongside supplementation.